Endurance Wealth Management’s Q32 Bio QTTB Stock Holding History

Endurance Wealth Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1K	Hold	111	–	–	﹤0.01%	636
2023 Q1	$2K	Hold	111	–	–	﹤0.01%	615
2022 Q4	$3K	Hold	111	–	–	﹤0.01%	580
2022 Q3	$3K	Hold	111	–	–	﹤0.01%	548
2022 Q2	$4K	Hold	111	–	–	﹤0.01%	549
2022 Q1	$6K	Hold	111	–	–	﹤0.01%	551
2021 Q4	$7K	Hold	111	–	–	﹤0.01%	535
2021 Q3	$20K	Hold	111	–	–	﹤0.01%	452
2021 Q2	$12K	Buy	111 +55	+98%	+$6.86K	﹤0.01%	509
2021 Q1	$9K	Hold	56	–	–	﹤0.01%	540
2020 Q4	$11K	Hold	56	–	–	﹤0.01%	487
2020 Q3	$11K	Buy	+56	New	+$12.5K	﹤0.01%	463

Other funds holding QTTB

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Endurance Wealth Management's QTTB Position: Q2 2023 in Review

Endurance Wealth Management held its Q32 Bio (QTTB) position steady in Q2 2023 at 111 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Endurance Wealth Management first reported a position in QTTB in Q3 2020 and has held it in 12 quarters since. The position peaked at $20K in Q3 2021. 59 funds tracked by Wall St. Rank hold QTTB as of Q2 2023.

Endurance Wealth Management held 111 shares of Q32 Bio worth $1K as of Q2 2023.
Endurance Wealth Management left its Q32 Bio share count unchanged in Q2 2023.
Q32 Bio made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #636 holding.
Endurance Wealth Management first reported a position in Q32 Bio in Q3 2020 and has held it in 12 quarters since.
Endurance Wealth Management's Q32 Bio position peaked at $20K in Q3 2021.
59 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.